You are not currently logged in.
Access JSTOR through your library or other institution:
Prediction Model to Identify Patients With Staphylococcus aureus Bacteremia at Risk for Methicillin Resistance
Thomas P. Lodise , Jr., PharmD, Peggy S. McKinnon , PharmD and Michael Rybak , PharmD
Infection Control and Hospital Epidemiology
Vol. 24, No. 9 (September 2003), pp. 655-661
Published by: Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Stable URL: http://www.jstor.org/stable/10.1086/502269
Page Count: 7
Preview not available
OBJECTIVES. To identify institution‐specific risk factors for MRSA bacteremia and develop an objective mechanism to estimate the probability of methicillin resistance in a given patient with Staphylococcus aureus bacteremia (SAB). DESIGN . A cohort study was performed to identify institution‐specific risk factors for MRSA. Logistic regression was used to model the likelihood of MRSA. A stepwise approach was employed to derive a parsimonious model. The MRSA prediction tool was developed from the final model. SETTING. A 279‐bed, level 1 trauma center. PATIENTS. Between January 1, 1999, and June 30, 2001, 494 patients with clinically significant episodes of SAB were identified. RESULTS. The MRSA rate was 45.5%. Of 18 characteristics included in the logistic regression, the only independent features for MRSA were prior antibiotic exposure (OR, 9.2; CI95, 4.8 to 17.9), hospital onset (OR, 3.0; CI95, 1.9 to 4.9), history of hospitalization (OR, 2.5; CI95, 1.5 to 3.8), and presence of decubitus ulcers (OR, 2.5; CI95, 1.2 to 4.9). The prediction tool was derived from the final model, which was shown to accurately reflect the actual MRSA distribution in the cohort. CONCLUSION. Through multivariate modeling techniques, we were able to identify the most important determinants of MRSA at our institution and develop a tool to predict the probability of methicillin resistance in a patient with SAB. This knowledge can be used to guide empiric antibiotic selection. In the era of antibiotic resistance, such tools are essential to prevent indiscriminate antibiotic use and preserve the longevity of current antimicrobials.
© 2003 by The Society for Healthcare Epidemiology of America. All rights reserved.